ITC Consumer Spending: ITC has announced a 4.6% increase in consumer spending on its FMCG products, reaching nearly Rs 34,000 crore in FY25. The company has also launched 100 new products catering ...

Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data from an indirect treatment comparison (ITC) study. The data show that ...

Reliance Industries to consolidate FMCG brands under new subsidiary ahead of IPO The restructuring will consolidate RIL’s FMCG portfolio, previously spread across Reliance Retail Ventures (RRVL ...

Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...

HUL’s FMCG Strategy 2.0: Affordability, digital acceleration, D2C drive at core of FY26 ambitions, says Nuvama Hindustan Unilever is banking on rural demand, digital expansion, and affordability ...

GMG:CA Company Profile Graphene Manufacturing Group Ltd, a clean-technology, provides energy saving and energy storage solutions enabled by graphene in Australia.

J&J files FcRn blocker nipocalimab for generalised myasthenia gravis (gMG) in US, setting up a challenge to rival drugs from Argenx and UCB ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Review the current Graphene Manufacturing Group Ltd (GMG:XTSX) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if GMG is the best investment for you.

Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for generalised myasthenia gravis (gMG).